And for that gap in public knowledge, well, the pharma companies must bear some of the blame.   While the drugmakers have been busy hawking costly pills for erectile dysfunction and pricey injections for wrinkles, they have neglected to explain the overall enervation of the   sector, and what that   recession means for patients and future patients. In other words, itâ€™s perfectly clear: In seeking maximum profits in the short run, the industry has hurt itself in the long run.   